Update on cellular encapsulation.

Area of Science:

• Biomedical Engineering
• Transplantation Immunology
• Regenerative Medicine

Background:

• Significant disparity between organ demand and donor availability for transplantation.
• Historical challenges in xenotransplantation due to immunologic incompatibilities.
• Encapsulation as a potential strategy to overcome immune rejection without immunosuppression.

Purpose of the Study:

• To review the role of encapsulation in xenotransplantation.
• To discuss current clinical trial status and persistent challenges.
• To highlight recent advancements addressing xenotransplantation limitations.

Main Methods:

• Review of existing literature on encapsulation techniques for xenotransplantation.
• Analysis of current clinical trials involving encapsulated xenogeneic cells.
• Discussion of innovations including bioprinting, immune modulation, and genetic engineering.

Main Results:

• Encapsulation shows potential for immune evasion in xenotransplantation.
• Advancements in bioprinting and genetic modification enhance xenograft survival.
• Key challenges include antigen shedding, oxygen supply, and donor selection.

Conclusions:

• Encapsulation combined with modern technologies is advancing cell-based xenogeneic therapeutics.
• Addressing antigen shedding, oxygen availability, and donor selection is crucial for clinical success.
• Xenotransplantation holds promise for treating conditions like liver failure and pain.